Water deionisation technology specialist Voltea has secured €6 million ($6.7 million) of capital from a syndicate of investors including Rabobank, ETF, Unilever, and new backer Anterra Capital.
The company wants to use the funds to expand sales of CapDI, its water deionisation system, in global industrial and commercial water treatment markets, and in residential water softener markets. Specifically, the capital will be used to hire engineering and sales talent, and to bring to market an automated, robotic module assembly facility.
“We are extremely excited by this investment and the expertise of our investor syndicate. The industry has been transitioning from validating whether CapDI works, to accepting and implementing it in a broad array of applications. As a result, we have entered an exciting time of commercial expansion where our manual production capacity has been outstripped by market demand. We will use the capital to expand and strengthen our global sales team, to extend engineering depth, and to increase production capacity,” said Voltea chief executive Bryan Brister.
Anterra Capital managing partner Adam Anders added: “We have known Voltea for many years and are impressed by the accelerated commercial progress they’ve made over the past 18 months. CapDI systems have been proven in multiple applications. That’s a great investment for Anterra Capital.”